Leptin receptor gene polymorphisms and risk of hypertension: a meta-analysis.

IF 0.2 Q4 MEDICINE, RESEARCH & EXPERIMENTAL International journal of clinical and experimental medicine Pub Date : 2015-08-15 eCollection Date: 2015-01-01

Yingdong Lian, Zhijun Tang, Yuxi Xie, Zongxiang Chen

{"title":"Leptin receptor gene polymorphisms and risk of hypertension: a meta-analysis.","authors":"Yingdong Lian, Zhijun Tang, Yuxi Xie, Zongxiang Chen","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: To assess the relationship between the polymorphisms of leptin receptor gene and hypertension.Methods: Meta analysis was conducted by using RevMan 5.3. Relevant literatures were retrieved by searching PubMed using the keywords \"Hypertension\", \"Leptin Receptor\", \"OB Receptor\", \"LEPR Protein\".Results: Fifteen studies with a total of 5955 patients with hypertension and 3830 healthy controls were included in this meta-analysis. The results showed that Gln223Arg gene polymorphism was significantly higher in hypertension patients than in control (OR=1.36, 95% CI=1.23-1.51, P<0.00001). However, no statistically significant difference was found in Lys109Arg polymorphism between hypertension patients and control (OR=0.99, 95% CI=0.85-1.16, P=0.91).Conclusion: Gln223Arg, but not Lys109Arg gene polymorphism, is higher in hypertension patients, suggesting that patients with Gln223Arg allele carry a higher risk to develop hypertension.","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 8","pages":"14277-82"},"PeriodicalIF":0.2000,"publicationDate":"2015-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613096/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical and experimental medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2015/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To assess the relationship between the polymorphisms of leptin receptor gene and hypertension.

Methods: Meta analysis was conducted by using RevMan 5.3. Relevant literatures were retrieved by searching PubMed using the keywords "Hypertension", "Leptin Receptor", "OB Receptor", "LEPR Protein".

Results: Fifteen studies with a total of 5955 patients with hypertension and 3830 healthy controls were included in this meta-analysis. The results showed that Gln223Arg gene polymorphism was significantly higher in hypertension patients than in control (OR=1.36, 95% CI=1.23-1.51, P<0.00001). However, no statistically significant difference was found in Lys109Arg polymorphism between hypertension patients and control (OR=0.99, 95% CI=0.85-1.16, P=0.91).

Conclusion: Gln223Arg, but not Lys109Arg gene polymorphism, is higher in hypertension patients, suggesting that patients with Gln223Arg allele carry a higher risk to develop hypertension.

微信好友朋友圈 QQ好友复制链接

本刊更多论文

瘦素受体基因多态性与高血压风险：一项荟萃分析。

目的：评估瘦素受体基因多态性与高血压之间的关系：评估瘦素受体基因多态性与高血压之间的关系：使用 RevMan 5.3 进行 Meta 分析。以 "高血压"、"瘦素受体"、"OB 受体"、"LEPR 蛋白 "为关键词在 PubMed 上检索相关文献：本次荟萃分析共纳入了 15 项研究，涉及 5955 名高血压患者和 3830 名健康对照者。结果显示，高血压患者的 Gln223Arg 基因多态性明显高于对照组（OR=1.36，95% CI=1.23-1.51，PConclusion：高血压患者中Gln223Arg基因多态性较高，而Lys109Arg基因多态性较低，这表明Gln223Arg等位基因患者患高血压的风险较高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International journal of clinical and experimental medicine MEDICINE, RESEARCH & EXPERIMENTAL-

自引率

0.00%

发文量

期刊介绍： Information not localized